Filing Details
- Accession Number:
- 0001140361-15-010304
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-04 19:11:16
- Reporting Period:
- 2015-03-02
- Filing Date:
- 2015-03-04
- Accepted Time:
- 2015-03-04 19:11:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1437402 | Ardelyx Inc. | ARDX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1611193 | W Jeffrey Jacobs | C/O Ardelyx, Inc. 34175 Ardenwood Blvd, Suite 200 Fremont CA 94555 | Vp, Chemistry | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-03-02 | 981 | $15.81 | 46,666 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 24, 2014.
- Represents shares acquired under the Issuer's Employee Stock Purchase Plan on February 27, 2015.
- This transaction was executed in multiple trades in prices ranging from $15.51 to $16.16, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Billionaire Hedge Funds
